Predicted protein targets (top 5)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | MC4R | P32245 | 14/20 | 0.59 |
| ▸ | UGCG | Q16739 | 4/20 | 0.46 |
| ▸ | CYP3A4 | P08684 | 3/20 | 0.46 |
| ▸ | MC3R | P41968 | 3/20 | 0.44 |
| ▸ | MC5R | P33032 | 1/20 | 0.42 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL6730395 | 1.00 | MC4R (0.59) | MC4RUGCGCYP3A4MC3RMC5R | |
| SCHEMBL6730682 | 0.91 | MC4R (0.57) | MC4RUGCGCYP3A4MC3RMC5R | |
| SCHEMBL7233767 | 0.91 | MC4R (0.50) | MC4RUGCGCYP3A4MC3RMC5R | |
| SCHEMBL6739687 | 0.89 | MC4R (0.60) | MC4RUGCGCYP3A4MC3RMC5R | |
| SCHEMBL6739684 | 0.89 | MC4R (0.60) | MC4RUGCGCYP3A4MC3RMC5R | |
| SCHEMBL6739689 | 0.89 | MC4R (0.60) | MC4RUGCGCYP3A4MC3RMC5R | |
| SCHEMBL7233774 | 0.88 | MC4R (0.47) | MC4RUGCGCYP3A4 | |
| SCHEMBL6634230 | 0.88 | MC4R (0.47) | MC4RUGCGCYP3A4 | |
| SCHEMBL6738398 | 0.88 | MC4R (0.58) | MC4RUGCGCYP3A4MC3RMC5R | |
| SCHEMBL6738395 | 0.88 | MC4R (0.58) | MC4RUGCGCYP3A4MC3RMC5R |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-20040192676-A1 | Ligands of melanocortin receptors and compositions and methods related thereto | NEUROCRINE BIOSCIENCES, INC. | 2004-09-30 | — | — | US | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20040192676-A1 | Ligands of melanocortin receptors and compositions and methods related thereto | MC3R, MC1R, MC2R | MC4R 5/4885UGCG 1922/4885CYP3A4 1054/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.